U.S. Metals and Mining Stock News

NasdaqGM:BZAI
NasdaqGM:BZAISemiconductor

Blaize Holdings (BZAI) Revenue Surge Challenges Cautious Narratives Around Ongoing Losses

Setting the scene: Blaize Holdings's FY 2025 earnings snapshot Blaize Holdings (BZAI) just closed FY 2025 with fourth quarter revenue of US$23.8 million and basic EPS of US$0.03 loss, against trailing twelve month revenue of US$38.6 million and EPS of US$1.98 loss, alongside very large reported year over year revenue growth of 2,386%. The company has seen quarterly revenue move from US$0.001 million in Q4 FY 2024 to US$23.8 million in Q4 FY 2025. Over that span, EPS has ranged from US$1.61...
NYSE:LYV
NYSE:LYVEntertainment

Has Live Nation (LYV) Already Priced In Its Strong Multi‑Year Share Price Performance

Wondering if Live Nation Entertainment at around US$154.92 a share still offers value or if most of the upside is already reflected in the price? This breakdown will help you frame that question clearly. The stock has had a mixed recent run, with a 1% decline over the last week and a 2.1% decline over the last month. It is still sitting on a 6.6% year to date gain and a 22.2% return over the last year, alongside a 125.8% return over three years and an 83.0% return over five years. Recent...
NYSE:BWA
NYSE:BWAAuto Components

BorgWarner Vote Tests Shareholder Consent Rights And Support For Board

A shareholder proposal giving investors the right to act by written consent has been submitted at BorgWarner ahead of the upcoming annual meeting. BorgWarner's board has recommended a vote against the proposal, creating a clear split between management and the proponent. The outcome could influence how NYSE:BWA shareholders exercise governance rights between annual meetings. BorgWarner, trading as NYSE:BWA, is entering the annual meeting with governance in focus and a share price of $56.12...
NasdaqGS:MANH
NasdaqGS:MANHSoftware

AI Agents Test Manhattan Associates’ Moat And Valuation Story

AI powered autonomous agents such as Anthropic's Claude are emerging as cross platform tools that can handle complex workflows typically managed by enterprise software. Investors are starting to question how this could affect the role of traditional application layer providers, including Manhattan Associates (NasdaqGS:MANH), particularly around pricing power and profitability. This development has recently drawn more attention, yet it has not been a core focus of recent coverage that...
NasdaqGS:CTAS
NasdaqGS:CTASCommercial Services

Cintas (CTAS) Q3 2026 Net Margin Holds At 17.5% Reinforcing Bullish Narratives

Q3 2026 Earnings Snapshot Cintas (CTAS) has just reported Q3 2026 results with quarterly revenue of about US$2.8b and basic EPS of US$1.23, giving investors a fresh read on how the business is tracking this year. Over recent quarters the company has seen revenue move from US$2.50b in Q1 2025 to US$2.80b in Q2 2026, while basic EPS has shifted from US$1.12 to US$1.23, with trailing twelve month net profit margins around 17.5% helping to frame the quality of those earnings. See our full...
NasdaqGS:DAKT
NasdaqGS:DAKTElectronic

Assessing Daktronics (DAKT) Valuation After New Major League Baseball Display Wins

Daktronics (DAKT) is back in the spotlight after announcing three fresh major league baseball projects, including a new Mariners Fire TV outfield board in Seattle and large center field displays in Phoenix and Chicago. See our latest analysis for Daktronics. The recent major league baseball wins sit against a mixed share price backdrop, with a 7 day share price return of 5.88%, a 30 day share price return of 22.11% and a 1 year total shareholder return of 69.73%. This indicates that longer...
NasdaqGM:EPSN
NasdaqGM:EPSNOil and Gas

Epsilon Energy (EPSN) Margin Compression Reinforces Bearish Valuation Narrative After FY 2025 Results

Epsilon Energy (EPSN) has just posted its FY 2025 numbers with third quarter revenue of about US$9.0 million and basic EPS of US$0.05, set against trailing twelve month revenue of US$45.7 million and EPS of US$0.27 that came alongside 11.2% earnings growth and a trailing net margin of 12.9% compared with 17% a year earlier. Over recent quarters the company has seen revenue move from US$7.3 million in Q2 2024 to US$16.2 million in Q1 2025, then to US$9.0 million in Q3 2025. Quarterly EPS has...
OTCPK:BSEM
OTCPK:BSEMPharmaceuticals

BioStem Governance And Hospital Expansion Moves Shape Investor Focus

BioStem Technologies (OTCPK:BSEM) appointed Jodi Ungrodt as a new member of its Board of Directors and Chair of the Audit Committee. The company completed the acquisition of BioTissue Holdings Inc.'s surgical and wound assets, including a national sales force. The transaction expands BioStem's commercial reach into hospital settings and broadens its product portfolio. BioStem Technologies, trading at $4.92, sits at an interesting point in its share price history, with a 25.9% return year to...
NYSE:AME
NYSE:AMEElectrical

Is It Time To Reassess AMETEK (AME) After Its Strong Multi‑Year Share Price Run?

If you are wondering whether AMETEK at around US$215 per share looks expensive or offers value, it is helpful to separate price action from underlying worth. The stock has seen mixed moves recently, with a 1.2% gain over the last 7 days, a 7.0% decline over 30 days, and returns of 3.0% year to date, 22.5% over the past year, 54.4% over 3 years, and 74.2% over 5 years. These moves come alongside a steady stream of company updates and industry commentary that keep AMETEK on many investors'...
NYSE:ZH
NYSE:ZHInteractive Media and Services

Zhihu (ZH) Returns To Trailing Profitability Challenging Concerns Over Earnings Narrative

Zhihu (NYSE:ZH) has posted a mixed FY 2025 update, with Q3 revenue at C¥658.9 million and basic EPS of C¥0.58 loss per share, while trailing 12 month figures show revenue of C¥2.97 billion and basic EPS of C¥1.25. Over recent quarters, revenue has shifted from C¥933.8 million in Q2 2024 to C¥859.2 million in Q4 2024, then to C¥716.9 million in Q2 2025 and C¥658.9 million in Q3 2025. Net income moved from a C¥82.7 million loss in Q2 2024 to a C¥72.5 million profit in Q2 2025, before a C¥46.7...
NasdaqGS:FLYW
NasdaqGS:FLYWDiversified Financial

Assessing Flywire’s Valuation After Recent Share Price Momentum And Mixed Longer Term Returns

Why Flywire is On Investors’ Radar Today Flywire (FLYW) has been drawing attention after a stretch where its share price showed a mix of gains over the past month and declines across the past 3 months and year to date. Investors are weighing how this recent trading pattern lines up with the company’s fundamentals and global payments footprint. See our latest analysis for Flywire. With the share price at $12.40, Flywire’s recent 16.5% 1 month share price return contrasts with its 14.3% 3 month...
OTCPK:GLAS.F
OTCPK:GLAS.FPersonal Products

Glass House Brands (OTCPK:GLAS.F) Q3 Loss Renews Doubts On Path To Sustainable Profitability

Glass House Brands (OTCPK:GLAS.F) has just posted a mixed FY 2025 picture, with Q3 revenue of US$38.4 million and a basic EPS loss of US$0.19, set against trailing 12 month revenue of US$196.2 million and a basic EPS loss of US$0.23. Over recent quarters, the company has seen revenue range from US$53.0 million in Q4 2024 to US$59.9 million in Q2 2025, while basic EPS has swung between a profit of US$0.10 in Q4 2024 and a loss of US$0.19 in Q3 2025. This keeps the focus firmly on how...
NYSE:INSP
NYSE:INSPMedical Equipment

Inspire Medical Systems Governance Vote Arrives As Shares Trade Below Targets

Inspire Medical Systems (NYSE:INSP) has put forward a proposal to amend its Certificate of Incorporation. Shareholders are scheduled to vote on the amendment at the upcoming annual general meeting. The change targets the company’s core governance framework, which may influence how future decisions are approved and overseen. The vote comes at a time when Inspire Medical Systems shares trade around $51.41, with returns showing an 8.8% decline over the past week and 11.8% over the past month...
NasdaqGS:BRZE
NasdaqGS:BRZESoftware

Braze (BRZE) Q4 Revenue Near US$205 Million Reinforces Growth Narrative Despite Ongoing Losses

Braze (BRZE) just closed out FY 2026 with fourth quarter revenue of US$205.2 million and a basic EPS loss of US$0.29, while the trailing twelve months show revenue of US$738.2 million and a full year basic EPS loss of US$1.22. Over recent periods, the company has seen quarterly revenue move from US$160.4 million in Q4 FY 2025 to US$205.2 million in Q4 FY 2026, with basic EPS losses in those quarters of US$0.17 and US$0.29 respectively. With losses still weighing on margins, the latest numbers...
NasdaqCM:VELO
NasdaqCM:VELOMachinery

Velo3D (VELO) Quarterly Loss Of US$11.8 Million Tests Bullish Profitability Narratives

Velo3D (VELO) has released its latest FY 2025 figures, reporting Q3 revenue of US$13.6 million and a basic EPS loss of US$0.69, alongside net income excluding extra items of a US$11.8 million loss. This keeps the focus firmly on profitability rather than the top line alone. Over recent quarters, the company’s revenue moved from US$8.2 million in Q3 2024 to US$13.6 million in Q3 2025, while basic EPS shifted from a loss of US$37.54 to a loss of US$0.69 as net losses moved from US$23.1 million...
NYSE:NOAH
NYSE:NOAHCapital Markets

Noah Holdings (NYSE:NOAH) Margin Improvement Challenges Cautious Narratives After FY 2025 Results

Noah Holdings (NYSE:NOAH) has wrapped up FY 2025 with fourth quarter revenue of C¥733.2 million and net income, excluding extra items, of C¥12.8 million, setting the stage for investors to reassess the story at a share price of US$11.33. Over the past few quarters, the company has seen quarterly revenue move from C¥651.9 million in Q4 2024 to C¥614.6 million, C¥629.5 million and C¥632.9 million in the first three quarters of 2025. Over the same period, basic EPS stepped from C¥1.56 in Q4 2024...
NasdaqGM:EDAP
NasdaqGM:EDAPMedical Equipment

Persistent €19.6 Million Annual Loss Tests EDAP TMS (NasdaqGM:EDAP) Growth Narrative After Q3 Results

EDAP TMS (NasdaqGM:EDAP) has reported Q3 2025 revenue of €13.9 million, with a basic EPS loss of €0.13 and net income loss of €5.0 million, while the trailing twelve months show revenue of €63.8 million, basic EPS loss of €0.52 and a net income loss of €19.6 million. Over recent quarters, the company has reported revenue of €13.1 million in Q3 2024, €20.3 million in Q4 2024 and €16.0 million in Q2 2025. Quarterly EPS losses have ranged from €0.05 in Q4 2024 to €0.19 in Q1 2025. This...
NYSE:WDH
NYSE:WDHInsurance

Waterdrop (NYSE:WDH) Margin Expansion Reinforces Bullish AI Efficiency Narrative

Waterdrop (NYSE:WDH) has put solid numbers on the table for FY 2025 so far, with third quarter revenue of ¥974.9 million and basic EPS of ¥0.44, alongside trailing 12 month EPS of ¥1.40 supported by net income of ¥506.4 million on revenue of ¥3.25 billion. Over recent quarters the company has seen revenue move from ¥676.2 million in Q2 2024 to ¥753.7 million in Q1 2025 and then to ¥974.9 million in Q3 2025. Basic EPS progressed from ¥0.24 in Q2 2024 to ¥0.30 in Q1 2025 and ¥0.44 in Q3 2025,...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

FDA Warning On Anktiva Puts ImmunityBio Growth Story Under Scrutiny

The U.S. FDA has issued a warning letter to ImmunityBio over allegedly false and misleading promotional claims for its bladder cancer drug Anktiva. The letter focuses on how Anktiva has been marketed to healthcare professionals and patients, and requests corrective action from the company. This regulatory action introduces additional marketing and compliance risk for ImmunityBio at a time when its drug portfolio is gaining wider attention. For investors following ImmunityBio, ticker...
NasdaqGS:EEFT
NasdaqGS:EEFTDiversified Financial

Is It Time To Revisit Euronet Worldwide (EEFT) After Its Sharp One Year Share Price Slump?

Wondering whether Euronet Worldwide at a last close of US$67.11 still reflects its true worth, or if the market is mispricing the stock. The share price has been under pressure, with returns of a 0.8% decline over 7 days, a 4.8% decline over 30 days, a 9.4% decline year to date, and a 38.8% decline over the past year, adding to an already weak 3-year and 5-year picture of 38.5% and 51.5% declines. Recent news coverage has focused on Euronet Worldwide's position within the Diversified...
NYSE:KBH
NYSE:KBHConsumer Durables

KB Home (KBH) Margin Squeeze In Q1 2026 Reinforces Bearish Profitability Narrative

KB Home Q1 2026: Earnings slip as margins come under pressure KB Home (KBH) opened fiscal 2026 with Q1 revenue of US$1,077.0 million and basic EPS of US$0.53, alongside net income of US$33.4 million as investors weigh how these figures fit into the broader housing cycle. Over recent quarters the company has seen quarterly revenue move from US$1,391.8 million in Q1 2025 to a peak of US$1,999.9 million in Q4 2024 before easing back to US$1,077.0 million in the latest quarter. Quarterly basic...
NYSE:ACM
NYSE:ACMConstruction

AECOM’s San Diego School Deal Adds Support To Undervalued Share Story

AECOM (NYSE:ACM) has extended its multi decade partnership with San Diego Unified School District. The company has been selected as prime consultant to support school modernization, safety, security, and sustainability upgrades. The new role covers projects such as new classrooms, safety and security initiatives, and sustainability improvements across the district. AECOM operates at the intersection of infrastructure, buildings, and environmental services, and this new prime consultant role...
NasdaqCM:PAYS
NasdaqCM:PAYSDiversified Financial

Paysign (PAYS) Margin Expansion To 9.2% Reinforces Bullish Quality Narrative

Paysign (PAYS) has wrapped up FY 2025 with fourth quarter revenue of about US$22.8 million and basic EPS of US$0.02, set against trailing twelve month revenue of US$82.0 million and EPS of US$0.14 that follows reported earnings growth of 97.9% over the past year. The company has seen revenue move from US$56.5 million on a trailing basis in Q3 2024 to US$82.0 million by Q4 2025, while trailing EPS has shifted from US$0.15 to US$0.14. This sets up a story where investors are weighing 20.3%...
NYSE:FUBO
NYSE:FUBOInteractive Media and Services

Does FuboTV’s (FUBO) Odd Split Ratio Hint At A Deeper Capital Structure Reset?

FuboTV Inc. completed a 1-for-12.00048 stock split on March 24, 2026, rebalancing its share count and per-share price structure. This unusually granular split ratio highlights management’s focus on aligning FuboTV’s capital structure with listing requirements and investor accessibility objectives. Next, we’ll examine how this unconventional stock split ratio could influence FuboTV’s investment narrative and appeal to different investor groups. We've uncovered the 12 dividend fortresses...